Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mRNA
Biotech
Ionis rare disease candidate ekes out phase 3 win
Out of 54 patients with Alexander disease, those given zilganersen could walk an average of 33.3% faster in a 10-meter walk test at 61 weeks.
Darren Incorvaia
Sep 22, 2025 10:46am
Japan biotech inks RNA research pact that includes mRNA compounds
Sep 19, 2025 10:49am
Fierce Pharma
RFK Jr. blasts pharma industry, touts mRNA vaccine misinformation
Sep 4, 2025 3:51pm
Wave reports AATD win, but investors lukewarm
Sep 3, 2025 3:00pm
Novo seeks obesity refresh with $550M Replicate deal
Aug 28, 2025 7:00am
NIH head says public distrust prompted mRNA vaccine rollback
Aug 12, 2025 2:08pm